OPKO HEALTH, INC.

A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.

OPK | US

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 4400 BISCAYNE BLVD., 33137 MIAMI
Website:: https://www.opko.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on developing and commercializing innovative healthcare solutions. The company operates through two primary segments. Its pharmaceutical division develops novel therapies, with key products including NGENLA™, a long-acting human growth hormone treatment, and RAYALDEE®. The research pipeline focuses on multispecific therapies for cancer and infectious diseases, supported by partnerships with major pharmaceutical organizations. The diagnostics division, through its subsidiary BioReference Laboratories, is one of the largest full-service clinical reference laboratories in the U.S., offering a comprehensive portfolio of testing services to physicians and patients. By integrating its therapeutic and diagnostic capabilities, OPKO aims to establish leading positions in large, growing healthcare markets and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OPKO HEALTH, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO HEALTH, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for OPKO HEALTH, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Farmsintez ao Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.	Russian Federation	LIFE
FATE THERAPEUTICS INC Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.	United States of America	FATE
FENNEC PHARMACEUTICALS INC. Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.	United States of America	FENC
FibroBiologics, Inc. Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.	United States of America	FBLG
FIBROGEN INC Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.	United States of America	FGEN
Fine Foods & Pharmaceuticals Ntm Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.	Italy	FF
Flora Growth Corp. A diversified firm in pharma distribution, plant-based wellness, and digital assets.	United States of America	FLGC
Foghorn Therapeutics Inc. Pioneering medicines targeting the chromatin regulatory system to treat genetically defined cancers.	United States of America	FHTX
Formycon AG Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.	Germany	FYB
Fortress Biotech, Inc. Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.	United States of America	FBIO